PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer

ABSTRACT:

SUBMITTER: Wei X 

PROVIDER: S-EPMC12292163 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature